U.S. and Chinese regulators recently met in Beijing to
discuss audit oversight cooperation. Those meetings are of particular interest
in view of the questions which have been raised in recent months regarding the
financial statements of Chinese issuers whose shares are traded in U.S.
SciClone Settles FCPA Follow-on Derivative
Suit : In a settlement that involves a company with
significant Chinese operations -- and that also may represent something of a
template for the settlement of FCPA enforcement follow-on civil lawsuits --
SciClone Pharmaceuticals and the individual defendant...